Ekso Bionics Holdings, Inc. (EKSO) Downgraded to “Hold” at Zacks Investment Research
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday.
According to Zacks, “Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. “
Separately, B. Riley reissued a “buy” rating and set a $4.00 target price on shares of Ekso Bionics Holdings in a report on Monday, May 15th.
Shares of Ekso Bionics Holdings (EKSO) traded up 2.39% on Tuesday, hitting $2.14. The company’s stock had a trading volume of 160,474 shares. The firm’s market cap is $54.86 million. Ekso Bionics Holdings has a 52 week low of $0.99 and a 52 week high of $6.79. The stock’s 50-day moving average price is $1.61 and its 200-day moving average price is $3.11.
Ekso Bionics Holdings (NASDAQ:EKSO) last released its earnings results on Tuesday, May 9th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.03. The company had revenue of $1.44 million for the quarter, compared to analyst estimates of $2.38 million. Ekso Bionics Holdings had a negative return on equity of 788.27% and a negative net margin of 392.15%. Equities analysts expect that Ekso Bionics Holdings will post ($1.25) earnings per share for the current fiscal year.
WARNING: “Ekso Bionics Holdings, Inc. (EKSO) Downgraded to “Hold” at Zacks Investment Research” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/07/11/ekso-bionics-holdings-inc-ekso-downgraded-to-hold-at-zacks-investment-research.html.
A hedge fund recently raised its stake in Ekso Bionics Holdings stock. Carl Domino Inc raised its stake in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 262.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,966 shares of the company’s stock after buying an additional 34,008 shares during the period. Carl Domino Inc owned 0.21% of Ekso Bionics Holdings worth $193,000 as of its most recent SEC filing. 4.34% of the stock is owned by institutional investors and hedge funds.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.